|
|
 |
Areas of Emphasis
- Drug and Medical Device
- Product Liability Law
- General Business Litigation
- Contract Litigation
- Sales Practices Litigation
Distinctions
- Mid-South Rising Stars®, Personal Injury Defense: Products
- Mississippi Army National Guard
- Lieutenant Colonel (MS) (Retired)
- Judge Advocate General
- Graduate, Leadership Mississippi
- Graduate, Leadership Pine Belt
Education & Honors
- University of Mississippi, J.D., cum laude, 2000
- Mississippi Cases Editor, Mississippi Law Journal
- Appellate Competition Chair, Moot Court Board
- University of Southern Mississippi, B.S., Business Administration, 1992
|
|
Associations
- American Bar Association
- Defense Research Institute
- Drug and Medical Device Committee
- Mississippi Bar
- Mississippi Defense Lawyers Association
- Harrison County Bar Association
- National Guard Association
Bar Admissions
- Mississippi, 2000
- U.S. District Courts
- Mississippi: Northern and Southern Districts
- U.S. Court of Appeals
- 5th Circuit
- U.S. Supreme Court
|
| |
Legal Experience
- Member of Merck trial team in Vioxx litigation in following cases:
- Humeston v. Merck & Co., Inc.; No. ATL-L-2272-03-MT -- Superior Court of New Jersey Law Division: Atlantic County, New Jersey, 2005.
- Cona v. Merck & Co., Inc.; No. ATL-L-3553-05-MT -- Superior Court of New Jersey Law Division: Atlantic County, New Jersey, 2006.
- John McDarby v. Merck & Co., Inc.; No. ATL-L-1296- 05-MT-- Superior Court of New Jersey Law Division: Atlantic County, New Jersey, 2006.
- Albright v. Merck & Co., Inc.; No. CV-05-02316 -- Jefferson County Circuit Court, Alabama, 2006.
- Janssen Pharmaceutica Inc. v. Armond, 866 So.2d 1092 (Miss. 2004), is a decision of the Mississippi Supreme Court which significantly changed the landscape of litigation in Mississippi, declaring that joinder of plaintiffs in prescription drug cases, in many cases improper, was subject to strict scrutiny, resulting in severance of many claims and transfers to appropriate venues.
- Janssen Pharmaceutica Inc. v. Bailey, 878 So.2d 31 (Miss. 2004), is a decision of the Mississippi Supreme Court reversing a $48 million judgment awarded to ten plaintiffs in a product liability action involving a prescription drug.
- Janssen Pharmaceutica, Inc. v. Jackson, 886 So.2d 91 (Miss. 2004).
- Presided as judicial advisor on military separation boards.
- Member of trial team in following cases
- Sabrina Brierton Johnson v. Johnson & Johnson, et al., California trial involving first product liability case in connection with Children’s Motrin and Stevens-Johnson syndrome (2008)
- Stephanie Zundel v Johnson & Johnson, et al., New Jersey trial involving Children’s Motrin and Stevens-Johnson syndrome (2009)
- Karen Robinson v. Johnson & Johnson, et al., Illinois trial involving Children’s Motrin and Stevens-Johnson syndrome (2009)
- Thomas Gaines v. Johnson & Johnson, et al., California trial involving Children’s Motrin and Stevens-Johnson syndrome (2010)
- Hutto v. McNeil, et al., Louisiana trial involving acetaminophen overdose (2010)
|
|
